PRISM MediaWire

PRISM MarketView Launches Emerging Women’s Health Index

Global women’s health market projected to reach $67.07 billion by 2031

4 January 2024

SS Innovations Announces Strategic Partnership with Surgical Lab for Distribution in Africa

Pan African Medical Device Distributor Surgical Lab to place the SSi Mantra Surgical Robotic System in Healthcare Facilities across the African Continent

25 December 2023

Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished

Lipella Granted Two Orphan Drug Designations by FDA

20 December 2023

BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors

POMPANO BEACH, FLORIDA, December 19, 2023 - PRISM MediaWire - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today annou...

19 December 2023

CMS Establishes National Pricing for BioStem Technologies Product AmnioWrap2™

“This change means that AmnioWrap2™ (AW2) can now be offered to all Medicare providers throughout the country. BioStem Technologies is taking the lead in wound care innovation, leveraging our distinctive BioRetain® process. This is more than a breakthrough; it's a transf...

14 December 2023

Center for Medicare Services Established National Pricing of AmnioWrap2(TM)in All MAC Regions

Pricing Provides AmnioWrap2TM Reimbursement in All MAC Regions

14 December 2023

BioStem Technologies Appoints Industry Veteran, Thomas Dugan to Board of Directors

New York, December 13, 2023 - BioStem Technologies (OTC: BSEM) has announced the appointment of Thomas J. Dugan to the position of Chairman of the Board. Mr. Dugan brings a wealth of experience to the role, with proven, hands-on expertise as a senior executive who has ex...

13 December 2023

BioStem Technologies Bolsters Leadership with Appointment of Thomas Dugan to Board of Directors

POMPANO BEACH, FLORIDA, December 13, 2023 - PRISM MediaWire - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today annou...

13 December 2023

GK Financing LLC, a Subsidiary of American Shared Hospital Services, Announces Agreement to Reload Lovelace Medical Center with New Cobalt Sources and Software Upgrade

Installation expected to be Completed in Mid-2024

13 December 2023

MyMD Tackles Rheumatoid Arthritis with Launch of Phase 2 Trial in Early 2024

NEW YORK, NY, December 11, 2023 - The FDA has cleared an Investigational New Drug Application (IND) for MyMD Pharmaceuticals (Nasdaq: MYMD) to initiate a Phase 2 clinical trial of oral MYMD-1® as a treatment for rheumatoid arthritis (RA). The company plans to launch the...

11 December 2023